Skip to main content
FUL
NYSE Industrial Applications And Services

H.B. Fuller Reports Strong Q2, Finalizes £715M Acquisition with $3B Bridge Loan, and Continues Share Buybacks

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
9
Price
$60.74
Mkt Cap
$3.31B
52W Low
$48.71
52W High
$68.63
52W Position info
25% above low
Off High info
11% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

FUL sits 25% above its 52-week low of $48.71.

Summary

H.B. Fuller reported strong second-quarter financial results with significant increases in revenue, net income, and EPS, alongside a substantial improvement in free cash flow. The company also finalized a major acquisition of Advanced Medical Solutions for approximately £715 million, backed by $3.0 billion in bridge financing, and continued its share repurchase program.


Key Events · Earnings and Guidance · FUL

  • Strong Q2 Financial Performance

    Net revenue increased 5.8% to $950.3 million, net income attributable to H.B. Fuller rose 62.1% to $67.8 million, and diluted EPS grew 61.8% to $1.23 for the second quarter of 2026 compared to the prior year.

  • Significant Free Cash Flow Improvement

    Year-to-date free cash flow improved substantially to $12.8 million as of May 30, 2026, compared to a negative $6.7 million in the same period of 2025.

  • Major Acquisition Finalized with Bridge Financing

    The company finalized the acquisition of Advanced Medical Solutions Group plc for approximately £715 million (enterprise value). This was financed by entering into up to $3.0 billion in secured and unsecured bridge credit agreements on June 25, 2026.

  • Substantial Share Repurchase Program Activity

    H.B. Fuller repurchased $45.579 million of common stock during the second quarter of 2026 under its existing $300 million authorization.


Analysis · FUL · Industrial Applications And Services

This 10-Q confirms H.B. Fuller's strong financial momentum, with robust growth across key metrics and a positive shift in free cash flow. The detailed disclosure of the Advanced Medical Solutions acquisition, including the $3.0 billion bridge financing, is a critical update, signaling a significant strategic expansion. While the earnings and acquisition were previously announced, this filing provides the full financial context and details, including a material legal settlement accrual and ongoing share repurchases, which collectively present a comprehensive picture of the company's financial health and strategic direction.

At the time of this filing, FUL was trading at $60.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $48.71 to $68.63. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FUL - Latest Insights

FUL
Jul 20, 2026, 3:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $55.89
Real-time Price: $59.17 info
Change: +$3.28 (+6%) info
Market Cap: $3.183B info
FUL
Jun 26, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $63.25
Real-time Price: $59.17 info
Change: -$4.08 (-6%) info
Market Cap: $3.183B info
FUL
Jun 25, 2026, 3:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $60.99
Real-time Price: $59.17 info
Change: -$1.82 (-3%) info
Market Cap: $3.183B info
FUL
Jun 25, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $59.27
Real-time Price: $59.17 info
Change: -$0.100 (-0.17%) info
Market Cap: $3.183B info
FUL
Jun 25, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $62.75
Real-time Price: $59.17 info
Change: -$3.58 (-6%) info
Market Cap: $3.183B info